在体内MRI成像检测瘤相关的初始新血管化,使用超分子对比剂
Atsushi Mahara1, Keigo Shima2, Raghav Soni1
1Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Kishibe Shim-machi, Suita, Osaka 564-8565, Japan.
Colloids and surfaces. B, Biointerfaces
|August 27, 2023
概括
研究人员开发了一种新的超分子磁共振 (MR) 对比剂,用于瘤血管生成的全身成像. 这种药物可视化泄漏的早期瘤微血管及其随时间的成熟.
科学领域:
- 生物医学成像技术 生物医学成像技术
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 了解瘤血管生成对于癌症治疗至关重要.
- 目前用于微血管发育的全身成像方法不足.
- 需要新的对比剂来进行详细的微血管观测.
研究的目的:
- 开发一种超分子磁共振 (MR) 对比剂,用于长期,全组织观察瘤血管生成.
- 在体内可视化微血管结构和血液循环.
- 在发育过程中描述瘤微血管结构的动态变化.
主要方法:
- 合成和优化光素和Gd酸盐结合聚乙烯糖醇 (PEG).
- 谱学和药物动力学分析以确定合适的PEG结构 (约. 10kDa) 的时间.
- 使用开发的MR对比剂在质瘤细胞移植模型中评估微血管形成.
主要成果:
- 一种新的超分子MR对比剂成功开发.
- 药物可视化了微血管结构和血液循环.
- 早期 (5天) 瘤微血管被观察到有漏水,与对比剂扩散.
- 成熟的 (12天) 瘤内微血管显示出减少的泄漏,表明血管稳定.
结论:
- 开发的高分子MR对比剂能够长期观察瘤血管生成.
- 图像数据表明,早期的瘤微血管具有高度的透性,随着时间的推移变得更加连续.
- 这为瘤新血管化的发展阶段提供了新的见解.
更多相关视频
12:09A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
11.6K
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
14.0K
相关概念视频
01:19Imaging Studies VII: Vascular Imaging
29
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
29
01:24Magnetic Resonance Imaging
5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K